An overview of the Economic Costs of Neurodevelopmental Disorders in Sub-Saraharan Africa

Background: Neurodevelopmental disorders (NDDs), which include autism spectrum disorders, attention deficit/hyperactivity disorder, intellectual disabilities, and cerebral palsy, are a major global public health concern. In Sub-Saharan Africa (SSA), however, the economic consequences of NDDs are little researched and rarely addressed in health and social policy frameworks. This review looks at the available literature on the economic burden of NDDs in SSA, with an emphasis on direct healthcare expenses, indirect productivity losses, caregiver difficulties, and larger societal implications.
Methods: A narrative assessment of published literature was conducted to summarize the available knowledge on the economic costs of NDDs in SSA. The review included studies on healthcare costs, productivity losses, educational exclusion, employment constraints, and policy gaps in neurodevelopmental care.
Results: Despite sparse data, the findings indicate that the total economic impact of NDDs in SSA is significant and largely underestimated due to underdiagnosis, stigma, and inadequate health systems. Families regularly face catastrophic health-care costs and long-term financial strain, which contribute to cycles of poverty and health disparities. The lack of established support structures, early intervention programs, inclusive education policies, and specialized services exacerbates socioeconomic disparities. Furthermore, limited investment in research and service delivery has led to significant policy and resource allocation gaps.
Conclusion: NDDs have a huge economic impact in Sub-Saharan Africa, yet it is often overlooked. Multisectoral efforts are urgently required to increase early detection, access to care, and social inclusion. Investing in neurodevelopmental services fulfills both a human rights requirement and a cost-effective strategy for lowering long-term societal costs and promoting sustainable development.